Sanofi SEC filings SNY
Sanofi has 1,001 filings in SEC EDGAR's recent list, going back to Jul 29, 2010. Its latest annual report, Form 20-F, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 30, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 17, 2026 | — |
| S-8 POS | Filing | Feb 5, 2026 | — |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| 424B5 | Prospectus supplement | Oct 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| S-8 POS | Filing | Mar 21, 2025 | — |
| F-3ASR | Filing | Apr 4, 2024 | — |
| S-8 | Employee stock plan registration | Apr 4, 2024 | — |
| S-8 POS | Filing | Mar 15, 2024 | — |
| F-6EF | Filing | Dec 18, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| S-8 POS | Filing | Mar 13, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2022 | — |
| S-8 POS | Filing | May 17, 2022 | — |
| F-3ASR | Filing | Jul 30, 2021 | — |
| S-8 | Employee stock plan registration | May 17, 2021 | — |
| S-8 POS | Filing | Apr 23, 2021 | — |
| F-6 POS | Filing | Aug 4, 2020 | — |
| S-8 | Employee stock plan registration | May 26, 2020 | — |
| FWP | Free writing prospectus | May 26, 2020 | — |
| S-8 POS | Filing | May 13, 2020 | — |
| 424B5 | Prospectus supplement | Jun 14, 2018 | — |
| FWP | Free writing prospectus | Jun 13, 2018 | — |
| FWP | Free writing prospectus | Jun 13, 2018 | — |
| 424B5 | Prospectus supplement | Jun 12, 2018 | — |
| S-8 | Employee stock plan registration | Jun 8, 2018 | — |
| S-8 POS | Filing | May 15, 2018 | — |
| S-8 | Employee stock plan registration | May 19, 2017 | — |
| S-8 POS | Filing | May 16, 2017 | — |
| S-8 | Employee stock plan registration | May 10, 2016 | — |
| S-8 POS | Filing | Apr 25, 2016 | — |
| F-3ASR | Filing | Mar 15, 2016 | — |
| F-6 POS | Filing | Feb 13, 2015 | — |
| 424B3 | Prospectus | Mar 24, 2014 | — |
| S-8 | Employee stock plan registration | Nov 6, 2013 | — |
| F-6EF | Filing | Oct 31, 2013 | — |
| 424B5 | Prospectus supplement | Apr 5, 2013 | — |
| FWP | Free writing prospectus | Apr 3, 2013 | — |
| 424B5 | Prospectus supplement | Apr 3, 2013 | — |
| F-3ASR | Form f-3 asr | Mar 11, 2013 | — |
| 424B5 | Prospectus supplement | Sep 28, 2011 | — |
| FWP | Free writing prospectus | Sep 27, 2011 | — |
| 424B5 | Prospectus supplement | Sep 27, 2011 | — |
| 424B3 | Prospectus | May 9, 2011 | — |
| F-6 POS | Filing | Apr 29, 2011 | — |
| 424B3 | Prospectus | Mar 30, 2011 | — |
| F-4/A | Amendment no. 3 to form f-4 | Mar 28, 2011 | — |
| 424B5 | Prospectus supplement | Mar 24, 2011 | — |
| F-4/A | Amendment no. 2 to form f-4 | Mar 24, 2011 | — |
| FWP | Free writing prospectus | Mar 23, 2011 | — |
| FWP | Free writing prospectus | Mar 23, 2011 | — |
| 424B5 | Prospectus supplement | Mar 22, 2011 | — |
| F-4/A | Amendment no. 1 to form f-4 | Mar 18, 2011 | — |
| F-4 | Form f-4 | Mar 7, 2011 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SNY (Nasdaq), SNYNF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris, France
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1121404
- Former names
- SANOFI-AVENTIS (until May 9, 2011); SANOFI SYNTHELABO SA (until Aug 24, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.